Inhibiting the cGAS-STING pathway in myeloid cells effectively improves myocardial healing related to TET2 deficiency-induced DNA damage response

Yaling Dou , Yan Zhang , Logan Rivera , Tingting Hong , Shaohai Fang , Thuy Tien Tran , Yubin Zhou , James F. Martin , Yun Huang

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1741

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1741 DOI: 10.1002/ctm2.1741
RESEARCH ARTICLE

Inhibiting the cGAS-STING pathway in myeloid cells effectively improves myocardial healing related to TET2 deficiency-induced DNA damage response

Author information +
History +
PDF

Abstract

Myeloid-specific Tet2 depletion promotes neutrophil expansion upon myocardium infarction (MI);

Tet2-deficient myeloid cells exhibit increased genome instability and cGASSTING overactivation;

STING antagonist H-151 treatment reduces neutrophil expansion in Tet2- deficient mice after MI and mitigates deleterious cardiac outcomes.

Keywords

cGAS-STING / epigenetics / myocardial repair / TET2

Cite this article

Download citation ▾
Yaling Dou, Yan Zhang, Logan Rivera, Tingting Hong, Shaohai Fang, Thuy Tien Tran, Yubin Zhou, James F. Martin, Yun Huang. Inhibiting the cGAS-STING pathway in myeloid cells effectively improves myocardial healing related to TET2 deficiency-induced DNA damage response. Clinical and Translational Medicine, 2024, 14(6): e1741 DOI:10.1002/ctm2.1741

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

SuttonMG, SharpeN. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101(25):2981-2988.

[2]

de FreitasEV, Batlouni M, GamarskyR. Heart failure in the elderly. J Geriatr Cardiol. 2012;9(2):101-107.

[3]

VigenR, MaddoxTM, AllenLA. Aging of the United States population: impact on heart failure. Curr Heart Fail Rep. 2012;9(4):369-374.

[4]

NahrendorfM. Myeloid cell contributions to cardiovascular health and disease. Nat Med. 2018;24(6):711-720.

[5]

RurikJG, Aghajanian H, EpsteinJA. Immune cells and immunotherapy for cardiac injury and repair. Circ Res. 2021;128(11):1766-1779.

[6]

TallAR, FusterJJ. Clonal hematopoiesis in cardiovascular disease and therapeutic implications. Nat Cardiovasc Res. 2022;1(2):116-124.

[7]

JaiswalS, Natarajan P, SilverAJ, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111-121.

[8]

FusterJJ, MacLauchlan S, ZuriagaMA, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842-847.

[9]

SanoS, OshimaK, WangY, et al. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1beta/NLRP3 inflammasome. J Am Coll Cardiol. 2018;71(8):875-886.

[10]

NahrendorfM, Swirski FK, AikawaE, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204(12):3037-3047.

[11]

LeuschnerF, RauchPJ, UenoT, et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med. 2012;209(1):123-137.

[12]

HorckmansM, RingL, DucheneJ, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. 2017;38(3):187-197.

[13]

PuhlSL, Steffens S. Neutrophils in post-myocardial infarction inflammation: damage vs. resolution? Front Cardiovasc Med. 2019;6:25.

[14]

Arruda-OlsonAM, ReederGS, BellMR, Weston SA, RogerVL. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes. 2009;2(6):656-662.

[15]

TahilianiM, KohKP, ShenY, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930-935.

[16]

ItoS, ShenL, DaiQ, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333(6047):1300-1303.

[17]

HeYF, LiBZ, LiZ, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333(6047):1303-1307.

[18]

CalcagnoDM, NgRP, ToomuA, et al. The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages. Sci Immunol. 2020;5(51):eaaz1974.

[19]

AnJ, Gonzalez-Avalos E, ChawlaA, et al. Acute loss of TET function results in aggressive myeloid cancer in mice. Nat Commun. 2015;6:10071.

[20]

KaferGR, LiX, HoriiT, et al. 5-Hydroxymethylcytosine marks sites of DNA damage and promotes genome stability. Cell Rep. 2016;14(6):1283-1292.

[21]

GeorgesRO, Sepulveda H, AngelJC, et al. Acute deletion of TET enzymes results in aneuploidy in mouse embryonic stem cells through decreased expression of Khdc3. Nat Commun. 2022;13(1):6230.

[22]

ValdiglesiasV, GiuntaS, FenechM, Neri M, BonassiS. gammaH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res. 2013;753(1):24-40.

[23]

MigliettaG, RussoM, CapranicoG. G-quadruplex-R-loop interactions and the mechanism of anticancer G-quadruplex binders. Nucleic Acids Res. 2020;48(21):11942-11957.

[24]

KumarC, BatraS, GriffithJD, Remus D. The interplay of RNA:dNA hybrid structure and G-quadruplexes determines the outcome of R-loop-replisome collisions. Elife. 2021;10:e72286.

[25]

SmolkaJA, SanzLA, HartonoSR, Chedin F. Recognition of RNA by the S9.6 antibody creates pervasive artifacts when imaging RNA:dNA hybrids. J Cell Biol. 2021;220(6):e202004079.

[26]

ZhaoH, ZhuM, LimboO, Russell P. RNase H eliminates R-loops that disrupt DNA replication but is nonessential for efficient DSB repair. EMBO Rep. 2018;19(5):e45335.

[27]

MotwaniM, Pesiridis S, FitzgeraldKA. DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Genet. 2019;20(11):657-674.

[28]

SunL, WuJ, DuF, ChenX, ChenZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339(6121):786-791.

[29]

WuJ, SunL, ChenX, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013;339(6121):826-830.

[30]

ZhaoB, XuP, RowlettCM, et al. The molecular basis of tight nuclear tethering and inactivation of cGAS. Nature. 2020;587(7835):673-677.

[31]

StetsonDB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006;24(1):93-103.

[32]

MeiselM, Hinterleitner R, PacisA, et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature. 2018;557(7706):580-584.

[33]

HaagSM, GulenMF, ReymondL, et al. Targeting STING with covalent small-molecule inhibitors. Nature. 2018;559(7713):269-273.

[34]

MaY, Yabluchanskiy A, LindseyML. Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrog Tissue Repair. 2013;6(1):11.

[35]

ChenGY, NunezG. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826-837.

[36]

CaoDJ, Schiattarella GG, VillalobosE, et al. Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury. Circulation. 2018;137(24):2613-2634.

[37]

AarrebergLD, Esser-Nobis K, DriscollC, ShuvarikovA, RobyJA. Interleukin-1beta induces mtDNA release to activate innate immune signaling via cGAS-STING. Mol Cell. 2019;74(4):801-815.e6.

[38]

AhnJ, SonS, OliveiraSC, Barber GN. STING-dependent signaling underlies IL-10 controlled inflammatory colitis. Cell Rep. 2017;21(13):3873-3884.

[39]

WuJ, RamanA, CoffeyNJ, et al. The key role of NLRP3 and STING in APOL1-associated podocytopathy. J Clin Invest. 2021;131(20):e136329.

[40]

LioCW, ZhangJ, Gonzalez-AvalosE, HoganPG, ChangX, RaoA. Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility. Elife. 2016;5:e18290.

[41]

TakagawaJ, ZhangY, WongML, et al. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol (1985). 2007;102(6):2104-2111.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

199

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/